U.S. markets close in 4 hours 29 minutes
  • S&P 500

    4,402.16
    +0.70 (+0.02%)
     
  • Dow 30

    35,020.92
    -37.60 (-0.11%)
     
  • Nasdaq

    14,742.78
    +82.21 (+0.56%)
     
  • Russell 2000

    2,204.57
    +12.74 (+0.58%)
     
  • Crude Oil

    72.07
    +0.42 (+0.59%)
     
  • Gold

    1,799.20
    -0.60 (-0.03%)
     
  • Silver

    24.92
    +0.27 (+1.10%)
     
  • EUR/USD

    1.1812
    -0.0014 (-0.12%)
     
  • 10-Yr Bond

    1.2590
    +0.0250 (+2.03%)
     
  • GBP/USD

    1.3880
    +0.0002 (+0.01%)
     
  • USD/JPY

    110.0750
    +0.3080 (+0.28%)
     
  • BTC-USD

    39,624.33
    +1,305.15 (+3.41%)
     
  • CMC Crypto 200

    929.98
    +0.05 (+0.01%)
     
  • FTSE 100

    7,018.82
    +22.74 (+0.33%)
     
  • Nikkei 225

    27,581.66
    -388.56 (-1.39%)
     

Is Genpact Limited's (NYSE:G) Stock's Recent Performance A Reflection Of Its Financial Health?

·4 min read

Genpact's (NYSE:G) stock is up by 5.5% over the past three months. Given its impressive performance, we decided to study the company's key financial indicators as a company's long-term fundamentals usually dictate market outcomes. In this article, we decided to focus on Genpact's ROE.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.

View our latest analysis for Genpact

How Do You Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Genpact is:

18% = US$315m ÷ US$1.8b (Based on the trailing twelve months to September 2020).

The 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each $1 of shareholders' capital it has, the company made $0.18 in profit.

What Has ROE Got To Do With Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

Genpact's Earnings Growth And 18% ROE

At first glance, Genpact seems to have a decent ROE. Further, the company's ROE compares quite favorably to the industry average of 14%. This probably laid the ground for Genpact's moderate 5.7% net income growth seen over the past five years.

We then compared Genpact's net income growth with the industry and found that the company's growth figure is lower than the average industry growth rate of 12% in the same period, which is a bit concerning.

past-earnings-growth
past-earnings-growth

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Genpact is trading on a high P/E or a low P/E, relative to its industry.

Is Genpact Using Its Retained Earnings Effectively?

Genpact has a low three-year median payout ratio of 20%, meaning that the company retains the remaining 80% of its profits. This suggests that the management is reinvesting most of the profits to grow the business.

Additionally, Genpact has paid dividends over a period of four years which means that the company is pretty serious about sharing its profits with shareholders. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 19% of its profits over the next three years. Accordingly, forecasts suggest that Genpact's future ROE will be 19% which is again, similar to the current ROE.

Conclusion

On the whole, we feel that Genpact's performance has been quite good. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. As a result, the decent growth in its earnings is not surprising. Having said that, looking at the current analyst estimates, we found that the company's earnings are expected to gain momentum. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.